Patents by Inventor Julia Adam

Julia Adam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070082931
    Abstract: Disclosed herein are indole derivatives of the formula (I) wherein each of the substitutents is given the definition as set forth in the specification and claims. Also disclosed are pharmaceutical compositions containing the indole derivatives and use of the derivatives for the treatment of pain.
    Type: Application
    Filed: August 18, 2006
    Publication date: April 12, 2007
    Applicant: AKZO NOBLE N.V.
    Inventors: Paul Ratcliffe, Julia Adam-Worrall, Angus Morrison, Stuart Francis, Takao Kiyoi
  • Publication number: 20050250760
    Abstract: The present invention relates to 1-[(indol-3-yl)carbonyl]piperazine derivative according to the general formula I or a pharmaceutically acceptable salt thereof. The invention also relates to pharmaceutical compositions comprising said 1-[(indol-3-yl)carbonyl]piperazine derivatives, and to the use of these derivatives in the treatment of pain, such as peri-operative pain, chronic pain neuropathic pain, cancer pain, and pain and spasticity associated with multiple sclerosis.
    Type: Application
    Filed: June 13, 2003
    Publication date: November 10, 2005
    Inventors: Phillip Cowley, Wilson Caulfield, Jason Tierney, James Cairns, Julia Adam-Worrall, Mark York
  • Publication number: 20040220175
    Abstract: The present invention relates to (pyrido/thieno)-[f]-oxazepine-5-one derivatives having the general Formula I wherein R1, R2 and R3 are independently H or (C1-4)alkyl; Ar represents a fused thiophene or pyridine ring optionally substituted with one or more substituents selected from (C1-4)alkyl, (C1-4)alkyloxy, (C1-4)alkyloxy(C1-4)alkyl, CF3, halogen, nitro, cyano, NR4R5, NR4COR6, and CONR4R5; R4 and R5 are independently H or (C1-4)-alkyl; or R4 and R5 form together with the nitrogen atom to which they are bound a 5-or 6-membered saturated heterocyclic ring, optionally containing a further heteroatom selected from O, S or NR6; R6 is (C1-4)alkyl; A represents the residue of a 4-7 membered saturated heterocyclic ring, optionally containing an oxygen atom, the ring being optionally substituted with 1-3 substituents selected from (C1-4)alkyl, (C1-4)-alkyloxy, hydroxy, halogen and oxo; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 14, 2004
    Publication date: November 4, 2004
    Inventors: Simon James Anthony Grove, Julia Adam-Worall, Minggiang Zhang, Robert Gilfillan